Zymogenetics Inc.
USPTO PatentsView assignee record - 54 granted patents across 7 technology areas, recorded in grant years 2015–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).
The verdict
According to USPTO PatentsView, Zymogenetics ranks #6,302 of 49,997 tracked US assignees by granted-patent volume, with 54 patents across 7 technology areas.
- #6,302
- of 49,997 US assignees by volume
- 32nd percentile
- by Innovation Score (29.9/100)
- 9.0
- avg claims per patent
- -83%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R6302 · US Corporation #6,302 · 54 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-USCORP · VEL-DROP · BOOK-FULL
- GRANTS-SMALL 54 grants
- UPPER-Q #6,302/49,997
- PHOTO-FINISH eYs3D Microelectronics
- CPC-NARROW C07K · 7 areas
- INNOV-THIN 29.9/100
- CLAIMS-PAR 9.0 claims/avg
- TYPE-USCORP US Corporation
- VEL-DROP -83% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: eYs3D Microelectronics, Co. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Zymogenetics’s 29.9 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Zymogenetics
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Nanchang O-film Tech · near 30
Nanchang O-film Tech · near
30 score
- Sultan Qaboos… · near 30
Sultan Qaboos… · near
30 score
- Zymogenetics · this assignee 30
Zymogenetics · this assignee
30 score
- Global Oled Technology · near 30
Global Oled Technology · near
30 score
- Theragun · near 30
Theragun · near
30 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Zymogenetics's Innovation Score is 29.9/100 (32nd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Zymogenetics?
Each dot is one of Zymogenetics’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Zymogenetics’s own 9.0 claims/patent is at or below the 15.3 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Zymogenetics's grants concentrate
Zymogenetics Inc. is a focused PatentsView assignee: 7 CPC subclasses with 94.4% of grants classified under C07K (Peptides). Peak complete grant year is 2017 (14 grants) versus a trough of 1 in 2022. By volume, Zymogenetics sits between Venus Medtech (HANGZHOU), Inc. and Advansix Resins & Chemicals LLC.
Zymogenetics's three-year grant acceleration
Zymogenetics Inc. shows 2 grants in 2022–2024 against only 10 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Zymogenetics's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Venus Medtech (Ha…
Venus Medtech (HANGZHOU), Inc.
54 patents
- Weir Minerals Aus…
Weir Minerals Australia Ltd.
54 patents
- Yuhan
Yuhan Corporation
54 patents
- Zimmer Knee Creat…
Zimmer Knee Creations, Inc.
54 patents
- eys3d Microelectr…
eYs3D Microelectronics, Co.
54 patents
- Zymogenetics ◀
Zymogenetics Inc.
54 patents
- 128 Technology
128 Technology, Inc.
53 patents
- Acergy France SAS
Acergy France SAS
53 patents
- Advansix Resins &…
Advansix Resins & Chemicals LLC
53 patents
What this shows Zymogenetics holds 54 patents at rank #6,301, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Zymogenetics
By rank, the assignees closest to #6,301 in granted patent volume.
- Venus Medtech (HANGZHOU), Inc. #6,297 · 54 patents
- Weir Minerals Australia Ltd. #6,298 · 54 patents
- Yuhan Corporation #6,299 · 54 patents
- Zimmer Knee Creations, Inc. #6,300 · 54 patents
- eYs3D Microelectronics, Co. #6,302 · 54 patents
- 128 Technology, Inc. #6,303 · 53 patents
- Acergy France SAS #6,304 · 53 patents
- Advansix Resins & Chemicals LLC #6,305 · 53 patents
Leaders in C07K (Peptides)
Other assignees with the most granted patents in Zymogenetics's primary technology class.
- The Regents of the University of California 894 in class
- Regeneron Pharmaceuticals, Inc. 824 in class
- Immatics Biotechnologies GmbH 678 in class
- Genentech, Inc. 565 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 513 in class
- The Trustees of the University of Pennsylvania 501 in class
- Novartis AG 407 in class
- The Board of Trustees of the Leland Stanford Junior University 400 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Zymogenetics, neither rank-band nor same-CPC leaders (those blocks stay above). In C07K (Peptides), Zymogenetics ranks #171 of 3,615 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (30 here).
Similar claim depth
Nearest assignees by average claims per patent (9.0 here).
Zymogenetics's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
30 32nd percentile higher than 32% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 12 | 22.2% |
| 2016 | 10 | 18.5% |
| 2017 | 14 | 25.9% |
| 2018 | 6 | 11.1% |
| 2019 | 4 | 7.4% |
| 2020 | 6 | 11.1% |
| 2022 | 1 | 1.9% |
| 2023 | 1 | 1.9% |
Which technologies does Zymogenetics Inc. patent most?
Top 7 of 7 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Zymogenetics Inc.'s patent record in context - here's where to go next.
- Zymogenetics Inc.'s lead technology class is C07K (Peptides), 94.4% of its portfolio - see every assignee active in that class. Explore C07K
- Ranked #6,302 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Zymogenetics Inc. against Venus Medtech (HANGZHOU), Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 29.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.